ALLMedicine™ Chronic Gastritis Center

Jan 12th, 2022 - This study aimed to investigate the diagnostic value of prealbumin-to-fibrinogen ratio (PFR) and albumin-to-fibrinogen ratio (AFR) alone or in combination in Helicobacter pylori-negative gastric cancer (Hp-NGC) patients. This study included 171 he...

Jan 10th, 2022 - Accurate risk stratification for gastric cancer is required for optimal endoscopic surveillance in patients with chronic gastritis. We aimed to develop a machine learning (ML) model that incorporates endoscopic and histological findings for an ind...

Dec 31st, 2021 - Helicobacter pylori infects half of the world population, being associated with several gastric disorders, such as chronic gastritis and gastric carcinoma. The Helicobacter genus also includes other gastric helicobacters, such as H. heilmannii¸ H....

Dec 24th, 2021 - Helicobacter pylori (H pylori) infection can cause chronic gastritis, peptic ulcer, and even gastric cancer, so effective eradication is critical.This study compared the efficacy and safety of bismuth quadruple regimens including either tetracycli...

Dec 21st, 2021 - This study was designed as a multi-center, randomized, double-blind, placebo-controlled, parallel-group, phase 3 study to assess the efficacy and safety of oral administration of DWP14012 X mg QD, Y mg BID and placebo for 2 weeks in patients with ...

Jul 7th, 2019 - Gastric adenocarcinoma carries a poor prognosis, in part due to the late stage of diagnosis. Risk factors include Helicobacter pylori infection, family history of gastric cancer-in particular, hereditary diffuse gastric cancer and pernicious anaem...

Dec 21st, 2021 - This study was designed as a multi-center, randomized, double-blind, placebo-controlled, parallel-group, phase 3 study to assess the efficacy and safety of oral administration of DWP14012 X mg QD, Y mg BID and placebo for 2 weeks in patients with ...

Aug 31st, 2021 - Abstract Introduction: H. pylori selectively infects the human stomach mucosa, being the most prevalent chronic infection in the world. Its prevalence correlates with socioeconomic factors and it is higher in older individuals. H. pylori presence ...

Jan 20th, 2021 - This project was an untargeted metabolomics study using liquid chromatography coupled with mass spectrometry (LC-MS) in patients with chronic gastritis and gastric carcinoma. The experimental procedures mainly include sample collection, metabolite...

Dec 2nd, 2020 - This is a multicenter, active-controlled , randomized, double-blinded, paralleled group clinical study to evaluate the efficacy and safety of AD-203 to demonstrate the non-inferiority of AD-203 compared with Mucosta tab. in patients with acute or ...

Nov 20th, 2020 - We conducted a large-scale multi-centre retrospective case-control study. Approximately a total of 1080 volunteers aging 40-75 in three independent cohorts, discovery cohort, validation cohort 1, validation cohort 2, will be recruited from 10 hosp...

May 17th, 2021 - Helicobacter pylori is a gram-negative microaerophilic bacterium that infects the epithelial lining of the stomach. It is the chief cause of chronic gastritis and the primary etiological agent for gastric cancer and peptic ulcer disease (PUD). Des...

Mar 25th, 2021 - A 4-mm punch biopsy was performed and revealed B-cell lymphoma, consistent with extranodal marginal zone lymphoma. The plaque was palpated carefully and the location of branches of the superficial temporal artery, which usually course anterior to.

Feb 19th, 2021 - Editor's Note: The Case Challenge series includes difficult-to-diagnose conditions, some of which are not frequently encountered by most clinicians but are nonetheless important to accurately recognize. Test your diagnostic and treatment skills us...

Dec 4th, 2020 - Lawrence M. Weiss, MD The PD-L1 immunohistochemistry (IHC) 22C3 pharmDx can be an aid in identifying patients with non—small cell lung cancer (NSCLC) and gastrointestinal cancers who are eligible for pembrolizumab (Keytruda) monotherapy, accordin...

Nov 23rd, 2020 - Helicobacter pylori (H. pylori) therapy and eradication protected against progression to gastric cancer in Hispanic patients with pre-cancerous lesions, and the protective effect of therapy endured at 20 years, researchers reported. In the longest...